Evolus financial statements

에볼러스NASDAQ:EOLS · Nasdaq · Healthcare · sector #16
$7.38-1.20%
2026-10-06 close · prelim

Evolus's published financial data is dated 2026-10-04. 2024 revenue was $266M. 2024 operating profit was −$34M.

Reported results

Evolus notifications

Quantus Signal · live data · not investment advice · Privacy Policy
Q